Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT00874783

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Led by Hadassah Medical Organization · Updated on 2025-03-04

120

Participants Needed

1

Research Sites

1130 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Human fibroblasts and possibly other human somatic cells may be reprogrammed into induced pluripotent stem (iPS) cells by the forced expression of transcription factors (1-5). The iPS cells seem to share many properties with human embryonic stem cells. Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from cell cultures from skin biopsies or the patient's hair. The iPS cells will be developed primarily for modeling diseases and drug discovery as well as basic research, and for developing the technology that may eventually allow the use of iPS cells for future transplantation therapy. The iPS cells developed in the course of this application are not intended for use in transplantation therapy. Future development of iPS cells for clinical transplantation therapies will be subjected to the appropriate authorization by ethical and regulatory committees.

CONDITIONS

Official Title

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Donors with specified neurodegenerative disorders scheduled for surgery or willing to donate intact hairs from the scalp or other body areas
  • Healthy donors scheduled for surgery or willing to donate intact hairs from the scalp or other body areas
Not Eligible

You will not qualify if you...

  • None

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hadassah Ein Kerem

Jerusalem, Israel, Israel, 9112100

Actively Recruiting

Loading map...

Research Team

B

Benjamin E. Reubinoff, MD PhD

CONTACT

S

Shelly E Tannenbaum, MSQA

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here